Telogen Effluvium and Anesthesia Considerations: A Case Report

    July 2025 in “ Cureus ”
    Elizabeth Johnson-Gray, Samantha A Currier, Hanen Fernandez, Matt Brown, Matthias Franzen
    Image of study
    TLDR Effective anesthesia strategies can help minimize hair loss in patients with telogen effluvium during surgery.
    This case report discusses telogen effluvium, a condition of temporary hair loss due to hair follicles prematurely entering the telogen phase, often triggered by stressors like surgery. The report presents a 61-year-old woman with a history of telogen effluvium who underwent surgery and highlights the anesthesia team's strategies to minimize exacerbation risks. These strategies included pain control, hydration, anxiety management, and avoiding known triggers like beta blockers and UV light. The patient experienced minimal hair loss post-surgery, suggesting that these techniques may help manage telogen effluvium during surgical procedures. However, the report emphasizes the need for further research to establish definitive guidelines for anesthesia considerations in such cases.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 552 results

    Similar Research

    5 / 1000+ results
      Telogen Effluvium: A Common Form of Hair Loss

      research Telogen Effluvium: A Common Form of Hair Loss

      July 2018 in “Elsevier eBooks”
      Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.
      Madarosis

      research Madarosis

      33 citations, November 2006 in “Survey of Ophthalmology”
      Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.
      Telogen Effluvium: A Review of Acute and Chronic Forms

      research Telogen Effluvium: A Review of Acute and Chronic Forms

      67 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.